This site is intended for US healthcare professionals.
How Does Toxicity Negatively Impact Efficacy?
If patients decline or cannot tolerate treatment, they do not have an opportunity to realize its potential benefits
The Impact Increases Post Second Line
Many patients with mRCC require dose reductions or interruptions to tolerate TKI treatment, including in the relapsed or refractory setting, leading to underutilization or no treatment3-7
In addition to posing a threat to the treatment plan and its potential clinical benefits, tolerability issues can cause negative effects on quality of life and increased supportive care interventions, and may discourage continued/additional treatment8-10
Across TKI pivotal trials,dose reductions,dose interruptions, and discontinuations due to AEs are high—
with dose interruptions affecting up to 4 out of 5 patients8,11
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!